---
input_text: 'Management of diabetes mellitus patients with sickle cell anemia: Challenges
  and therapeutic approaches. The coexistence of diabetes mellitus (DM) and sickle
  cell anemia (SCA) poses significant challenges in clinical management due to the
  complex interactions and overlapping complications associated with both conditions.
  Managing diabetes in individuals with SCA requires a comprehensive approach that
  addresses the unique physiological and pathological aspects of both diseases. This
  paper reviews the challenges encountered in the management of DM in patients with
  SCA and explores therapeutic strategies and approaches to optimize patient care.
  Challenges in the management of DM in individuals with SCA stem from several factors,
  including the impact of hemoglobin variants on glycemic control assessment, increased
  susceptibility to infections, altered immune response, and complications associated
  with both diseases. Moreover, the coexistence of SCA and DM heightens the susceptibility
  to infections due to compromised immune function, emphasizing the need for vigilant
  preventive measures, including vaccinations and close monitoring for infectious
  complications. Close collaboration among healthcare providers specializing in diabetes,
  hematology, and other relevant fields is crucial for developing comprehensive care
  plans. Individualized treatment strategies that balance glycemic control, pain management,
  and preventive care are essential to mitigate complications and optimize the overall
  health outcomes of patients with both DM and SCA. In conclusion, managing diabetes
  in the context of SCA necessitates a nuanced and patient-centered approach. By addressing
  the challenges and employing tailored therapeutic strategies, healthcare providers
  can improve the quality of life and health outcomes for individuals affected by
  both conditions.'
raw_completion_output: |-
  primary_disease: diabetes mellitus and sickle cell anemia
  medical_actions: managing diabetes; addressing unique physiological and pathological aspects; optimizing patient care; assessing glycemic control; increasing susceptibility to infections; altering immune response; providing vaccinations; close monitoring for infectious complications; developing comprehensive care plans; individualizing treatment strategies; balancing glycemic control; pain management; preventive care
  symptoms: complex interactions and overlapping complications; impact of hemoglobin variants on glycemic control; increased susceptibility to infections; altered immune response; complications associated with both diseases
  chemicals: 
  action_annotation_relationships: managing diabetes TREATS complex interactions and overlapping complications IN diabetes mellitus and sickle cell anemia; assessing glycemic control TREATS impact of hemoglobin variants on glycemic control IN diabetes mellitus and sickle cell anemia; providing vaccinations PREVENTS increased susceptibility to infections IN diabetes mellitus and sickle cell anemia; developing comprehensive care plans TREATS complications associated with both diseases IN diabetes mellitus and sickle cell anemia; individualizing treatment strategies TREATS complex interactions and overlapping complications IN diabetes mellitus and sickle cell anemia; balancing glycemic control TREATS impact of hemoglobin variants on glycemic control IN diabetes mellitus and sickle cell anemia; pain management TREATS complications associated with both diseases IN diabetes mellitus and sickle cell anemia
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  pain management TREATS complications associated with both diseases IN diabetes mellitus and sickle cell anemia

  ===

extracted_object:
  primary_disease: diabetes mellitus and sickle cell anemia
  medical_actions:
    - managing diabetes
    - addressing unique physiological and pathological aspects
    - optimizing patient care
    - assessing glycemic control
    - increasing susceptibility to infections
    - altering immune response
    - providing vaccinations
    - close monitoring for infectious complications
    - developing comprehensive care plans
    - individualizing treatment strategies
    - balancing glycemic control
    - MAXO:0000457
    - preventive care
  symptoms:
    - complex interactions and overlapping complications
    - impact of hemoglobin variants on glycemic control
    - increased susceptibility to infections
    - altered immune response
    - complications associated with both diseases
  action_annotation_relationships:
    - subject: managing diabetes
      predicate: TREATS
      object: complex interactions and overlapping complications
      qualifier: diabetes mellitus and sickle cell anemia
    - subject: assessing glycemic control
      predicate: TREATS
      object: impact of hemoglobin variants on glycemic control
      qualifier: diabetes mellitus and sickle cell anemia
    - subject: <providing vaccinations>
      predicate: <PREVENTS>
      object: <increased susceptibility to infections>
      qualifier: <diabetes mellitus and sickle cell anemia>
      subject_extension: <vaccinations>
    - subject: <developing comprehensive care plans>
      predicate: <TREATS>
      object: <complications associated with both diseases>
      qualifier: <diabetes mellitus and sickle cell anemia>
      subject_qualifier: <None>
      object_qualifier: <None>
      subject_extension: <None>
      object_extension: <None>
    - subject: individualizing treatment strategies
      predicate: TREATS
      object: complex interactions and overlapping complications
      qualifier: diabetes mellitus and sickle cell anemia
    - subject: balancing glycemic control
      predicate: TREATS
      object: impact of hemoglobin variants on glycemic control
      qualifier: diabetes mellitus and sickle cell anemia
    - subject: MAXO:0000457
      predicate: TREATS
      object: complications associated with both diseases
      qualifier: diabetes mellitus and sickle cell anemia
named_entities:
  - id: MONDO:0007374
    label: Sickle cell disease (SCD)
  - id: MAXO:0000457
    label: pain management
  - id: HP:0001903
    label: anemia
  - id: CHEBI:44423
    label: hydroxyurea
  - id: CHEBI:18050
    label: L-glutamine
  - id: MAXO:0000058
    label: pharmacotherapy
  - id: HP:0100602
    label: preeclampsia
  - id: HP:0001622
    label: preterm delivery
  - id: HP:0001511
    label: intrauterine growth restriction
  - id: CHEBI:50858
    label: corticosteroids
  - id: HP:0001907
    label: thromboembolism
  - id: MAXO:0000503
    label: Mechanical ventilation
  - id: MONDO:0011382
    label: Sickle Cell Disease
  - id: MAXO:0001001
    label: Gene therapies
  - id: HP:0025322
    label: VOD
  - id: CHEBI:82557
    label: Treosulfan
  - id: MAXO:0000750
    label: conditioning regimen
  - id: MONDO:0007885
    label: Osteonecrosis of the femoral head (AVNFH)
  - id: HP:0012531
    label: Pain
  - id: HP:0000969
    label: Oedema
  - id: MONDO:0018660
    label: hemophilia
  - id: HP:0012532
    label: Chronic pain
  - id: CHEBI:3216
    label: Buprenorphine
  - id: MAXO:0000747
    label: Hematopoietic stem cell transplantation
  - id: HP:0100543
    label: cognitive dysfunction
  - id: HP:0000739
    label: anxiety
  - id: CHEBI:50131
    label: Decitabine
  - id: CHEBI:29548
    label: Cytidine deaminase (CDA)
  - id: MONDO:0009693
    label: Multiple Myeloma
  - id: CHEBI:145536
    label: Motixafortide
  - id: MAXO:0000601
    label: Dialysis
  - id: HP:0000083
    label: Kidney failure
  - id: MONDO:0100096
    label: COVID-19
  - id: MAXO:0001017
    label: vaccination
  - id: CHEBI:28901
    label: busulfan
  - id: CHEBI:9570
    label: thiotepa
  - id: MAXO:0000952
    label: Hydration therapy
  - id: HP:0006775
    label: Myeloma
  - id: MAXO:0000756
    label: blood transfusions
  - id: MONDO:0005570
    label: Hematologic diseases
  - id: HP:0007760
    label: Sickle cell disease (SCD)
  - id: MAXO:0010203
    label: echocardiography
  - id: CHEBI:31980
    label: Definity
  - id: MAXO:0000149
    label: Hematopoietic stem cell transplantation (HCT)
  - id: HP:0001297
    label: stroke
  - id: CHEBI:6716
    label: Depot medroxyprogesterone acetate
  - id: CHEBI:50114
    label: Estrogen
  - id: CHEBI:59826
    label: Progestin
  - id: MONDO:0005161
    label: Human papillomavirus (HPV)
  - id: MAXO:0000759
    label: HPV vaccination
  - id: MAXO:0000194
    label: opioid therapy
  - id: MAXO:0000882
    label: behavioral modification
  - id: MAXO:0001298
    label: therapy
  - id: MAXO:0010041
    label: skin grafting
  - id: MONDO:0044348
    label: Hemoglobinopathies
  - id: HP:0002092
    label: Pulmonary hypertension
  - id: MAXO:0000573
    label: use of assisted reproductive technologies (ART)
  - id: HP:0000044
    label: hypogonadotropic hypogonadism (HH)
  - id: HP:0009800
    label: gestational diabetes mellitus
  - id: HP:0011891
    label: post-partum haemorrhage
  - id: HP:0002617
    label: Vasculopathy
  - id: CHEBI:15365
    label: Aspirin
  - id: MAXO:0000068
    label: Transplantation
  - id: HP:0004870
    label: Chronic hemolytic anemia
  - id: CHEBI:27690
    label: Acetazolamide
  - id: MAXO:0001175
    label: liver transplantation
  - id: HP:0000952
    label: jaundice
  - id: MAXO:0000602
    label: Hemodialysis
  - id: MONDO:0002492
    label: Acute kidney injury
  - id: HP:0002240
    label: Hepatomegaly
  - id: HP:0001744
    label: Splenomegaly
  - id: HP:0000790
    label: Hematuria
  - id: HP:0001919
    label: Acute kidney injury
  - id: HP:0001735
    label: acute pancreatitis
  - id: HP:0001953
    label: diabetic ketoacidosis
  - id: HP:0001873
    label: thrombocytopenia
  - id: HP:0001882
    label: leukopenia
  - id: HP:0003077
    label: hyperlipidemia
  - id: HP:0002155
    label: hypertriglyceridemia
  - id: CHEBI:9168
    label: Sirolimus
  - id: CHEBI:68554
    label: Deferiprone (L1)
  - id: CHEBI:4356
    label: Deferoxamine
  - id: MONDO:0010122
    label: congenital TTP
  - id: HP:0000789
    label: Infertility
